US2016016891A1PendingUtilityA1

Preparation of chiral amides and amines

52
Assignee: SUNOVION PHARMACEUTICALS INCPriority: Mar 31, 2006Filed: May 18, 2015Published: Jan 21, 2016
Est. expiryMar 31, 2026(expired)· nominal 20-yr term from priority
A61P 25/14A61P 25/04A61P 25/00A61P 25/18A61P 25/24A61P 29/00A61P 25/28A61P 25/08A61P 25/30A61P 25/22C07C 209/62C07C 211/42A61P 17/06C07C 249/08C07C 231/12A61P 19/02C07B 43/06C07C 209/50C07C 2602/10C07C 231/14C07C 2102/10
52
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This invention provides a convenient method for converting oximes into enamides. The process does not require the use of metallic reagents. Accordingly, it produces the desired compounds without the concomitant production of a large volume of metallic waste. The enamides are useful precursors to amides and amines. The invention provides a process to convert a prochiral enamide into the corresponding chiral amide. In an exemplary process, a chiral amino center is introduced during hydrogenation through the use of a chiral hydrogenation catalyst. In selected embodiments, the invention provides methods of preparing amides and amines that include the 1,2,3,4-tetrahydro-N-alkyl-1-naphthalenamine or 1,2,3,4-tetrahydro-1-naphthalenamine substructure.

Claims

exact text as granted — not AI-modified
1 .- 51 . (canceled) 
     
     
         52 . A process for preparing a single trans enantiomer of formula 
       
         
           
           
               
               
           
         
         wherein Q −  is an anion; and e is 0 or 1, said process comprising: 
         a) reacting a ketone of formula: 
       
       
         
           
           
               
               
           
         
         with hydroxylamine to form an oxime of formula: 
       
       
         
           
           
               
               
           
         
         b) reacting said oxime with acetic anhydride in the presence of a trialkylphosphine to produce an enamide of formula: 
       
       
         
           
           
               
               
           
         
         c) reducing said enamide with hydrogen in the presence of a chiral rhodium catalyst to produce a trans acetamide isomer of formula: 
       
       
         
           
           
               
               
           
         
       
       containing less than 10% of the corresponding, cis isomer 
       
         
           
           
               
               
           
         
       
       and
 d) hydrolyzing said trans acetamide isomer. 
 
     
     
         53 . A process according to  claim 52  wherein said single enantiomer is of formula: 
       
         
           
           
               
               
           
         
       
     
     
         54 . A process according to  claim 52  wherein said single enantiomer is of formula:

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.